Pharmaceutical Research

, Volume 28, Issue 6, pp 1338–1348 | Cite as

Optimal Construction and Delivery of Dual-Functioning Lentiviral Vectors for Type I Collagen-Suppressed Chondrogenesis in Synovium-Derived Mesenchymal Stem Cells

  • Feng Zhang
  • Yongchang Yao
  • Ruijie Zhou
  • Kai Su
  • Fudiman Citra
  • Dong-An Wang
Research Paper



This study aims to deliver both transforming growth factor β3 (TGF-β3) and shRNA targeting type I collagen (Col I) by optimal construction and application of various dual-functioning lentiviral vectors to induce Col I-suppressed chondrogenesis in synovium-derived mesenchymal stem cells (SMSCs).


We constructed four lentiviral vectors (LV-1, LV-2, LV-3 and LV-4) with various arrangements of the two expression cassettes in different positions and orientations. Col I inhibition efficiency and chondrogenic markers were assessed with qPCR, ELISA and staining techniques. Among the four vectors, LV-1 has two distant and reversely oriented cassettes, LV-2 has two distant and same-oriented cassettes, LV-3 has two proximal and reversely oriented cassettes, and LV-4 has two proximal and same-oriented cassettes. Col I and chondrogenic markers, including type II collagen (Col II), aggrecan and glycosaminoglycan (GAG), were examined in SMSCs cultured in 3-D alginate hydrogel.


All of the four vectors showed distinct effects in Col I level as well as diverse inductive efficiencies in upregulation of the cartilaginous markers. Based on real-time PCR results, LV-1 was optimal towards Col I-suppressed chondrogenesis.


LV-1 vector is competent to promote Col I-suppressed chondrogenesis in SMSCs.


dual-functioning lentiviral vector synovial mesenchymal stem cells (SMSCs) TGF-β3 type I collagen chondrogenesis 


Col I

type I collagen

Col II

type II collagen


recombinant lentiviral vector that expresses both shRNA targeting type I collagen and TGF- β3


recombinant lentiviral vector that specifically expresses TGF-β3


short hairpin RNA


synovium-derived mesenchymal stem cell


transforming growth factor-β3



This research was financially supported by AcRF Tier 1 Grant RG64/08, Ministry of Education (MoE), and NMRC/EDG/1001/2010, Singapore.

Supplementary material

11095_2010_305_MOESM1_ESM.docx (375 kb)
Esm 1 (DOCX 374 kb)


  1. 1.
    Schulzand RM, Bader A. Cartilage tissue engineering and bioreactor systems for the cultivation and stimulation of chondrocytes. Eur Biophys J. 2007;36:539–68.CrossRefGoogle Scholar
  2. 2.
    Buckwalter JA. Articular cartilage injuries. Clin Orthop Relat Res. 2002;21-37.Google Scholar
  3. 3.
    Fan J, Varshney RR, Ren L, Cai D, Wang DA. Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration. Tissue Eng Part B Rev. 2009;15:75–86.PubMedCrossRefGoogle Scholar
  4. 4.
    Chuang CK, Sung LY, Hwang SM, Lo WH, Chen HC, Hu YC. Baculovirus as a new gene delivery vector for stem cell engineering and bone tissue engineering. Gene Ther. 2007;14:1417–24.PubMedCrossRefGoogle Scholar
  5. 5.
    Hao J, Varshney RR, Wang DA. Engineering osteogenesis and chondrogenesis with gene-enhanced therapeutic cells. Curr Opin Mol Ther. 2009;11:404–10.PubMedGoogle Scholar
  6. 6.
    Park JS, Woo DG, Yang HN, Lim HJ, Chung HM, Park KH. Heparin-bound transforming growth factor-beta3 enhances neocartilage formation by rabbit mesenchymal stem cells. Transplantation. 2008;85:589–96.PubMedCrossRefGoogle Scholar
  7. 7.
    RR Varshney, R Zhou, J Hao, SS Yeo, WH Chooi, J Fan, DA Wang: Chondrogenesis of synovium-derived mesenchymal stem cells in gene-transferred co-culture system. Biomaterials. 31: 6876-91.Google Scholar
  8. 8.
    Mayne R, Vail MS, Mayne PM, Miller EJ. Changes in type of collagen synthesized as clones of chick chondrocytes grow and eventually lose division capacity. Proc Natl Acad Sci U S A. 1976;73:1674–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Yokoyama A, Sekiya I, Miyazaki K, Ichinose S, Hata Y, Muneta T. In vitro cartilage formation of composites of synovium-derived mesenchymal stem cells with collagen gel. Cell Tissue Res. 2005;322:289–98.PubMedCrossRefGoogle Scholar
  10. 10.
    Zhang F, Yao Y, Hao J, Zhou R, Liu C, Gong Y, Wang DA. A dual-functioning adenoviral vector encoding both transforming growth factor-beta3 and shRNA silencing type I collagen: construction and controlled release for chondrogenesis. J Control Release. 142:70–7.Google Scholar
  11. 11.
    Yao Y, Wang C, Varshney RR, Wang DA. Antisense makes sense in engineered regenerative medicine. Pharm Res. 2009;26:263–75.PubMedCrossRefGoogle Scholar
  12. 12.
    Brantl S. Antisense-RNA regulation and RNA interference. Biochim Biophys Acta. 2002;1575:15–25.PubMedGoogle Scholar
  13. 13.
    Spector JA, Mehrara BJ, Luchs JS, Greenwald JA, Fagenholz PJ, Saadeh PB, et al. Expression of adenovirally delivered gene products in healing osseous tissues. Ann Plast Surg. 2000;44:522–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Liand F, Mahato RI. Bipartite vectors for co-expression of a growth factor cDNA and short hairpin RNA against an apoptotic gene. J Gene Med. 2009;11:764–71.CrossRefGoogle Scholar
  15. 15.
    Yao Y, Zhang F, Zhou R, Su K, Fan J, Wang DA. Effects of combinational adenoviral vector-mediated TGF beta 3 transgene and shRNA silencing type I collagen on articular chondrogenesis of synovium-derived mesenchymal stem cells. Biotechnol Bioeng. 106:818–28.Google Scholar
  16. 16.
    De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001;44:1928–42.PubMedCrossRefGoogle Scholar
  17. 17.
    Ameer GA, Mahmood TA, Langer R. A biodegradable composite scaffold for cell transplantation. J Orthop Res. 2002;20:16–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Sah RL, Kim YJ, Doong JY, Grodzinsky AJ, Plaas AH, Sandy JD. Biosynthetic response of cartilage explants to dynamic compression. J Orthop Res. 1989;7:619–36.PubMedCrossRefGoogle Scholar
  19. 19.
    Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta. 1986;883:173–7.PubMedGoogle Scholar
  20. 20.
    Freed LE, Marquis JC, Nohria A, Emmanual J, Mikos AG, Langer R. Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res. 1993;27:11–23.PubMedCrossRefGoogle Scholar
  21. 21.
    Wilson C, Bellen HJ, Gehring WJ. Position effects on eukaryotic gene expression. Annu Rev Cell Biol. 1990;6:679–714.PubMedCrossRefGoogle Scholar
  22. 22.
    Wang P, Yang J, Ishihama A, Pittard AJ. Demonstration that the TyrR protein and RNA polymerase complex formed at the divergent P3 promoter inhibits binding of RNA polymerase to the major promoter, P1, of the aroP gene of Escherichia coli. J Bacteriol. 1998;180:5466–72.PubMedGoogle Scholar
  23. 23.
    Callen BP, Shearwin KE, Egan JB. Transcriptional interference between convergent promoters caused by elongation over the promoter. Mol Cell. 2004;14:647–56.PubMedCrossRefGoogle Scholar
  24. 24.
    Adhyaand S, Gottesman M. Promoter occlusion: transcription through a promoter may inhibit its activity. Cell. 1982;29:939–44.CrossRefGoogle Scholar
  25. 25.
    Prescottand EM, Proudfoot NJ. Transcriptional collision between convergent genes in budding yeast. Proc Natl Acad Sci U S A. 2002;99:8796–801.CrossRefGoogle Scholar
  26. 26.
    Epshtein V, Toulme F, Rahmouni AR, Borukhov S, Nudler E. Transcription through the roadblocks: the role of RNA polymerase cooperation. EMBO J. 2003;22:4719–27.PubMedCrossRefGoogle Scholar
  27. 27.
    Han Y, Lin YB, An W, Xu J, Yang HC, O'Connell K, et al. Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host Microbe. 2008;4:134–46.PubMedCrossRefGoogle Scholar
  28. 28.
    Hu X, Eszterhas S, Pallazzi N, Bouhassira EE, Fields J, Tanabe O, et al. Transcriptional interference among the murine beta-like globin genes. Blood. 2007;109:2210–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Bhosaleand AM, Richardson JB. Articular cartilage: structure, injuries and review of management. Br Med Bull. 2008;87:77–95.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Feng Zhang
    • 1
  • Yongchang Yao
    • 1
    • 2
    • 3
  • Ruijie Zhou
    • 1
  • Kai Su
    • 1
  • Fudiman Citra
    • 1
  • Dong-An Wang
    • 1
    • 3
  1. 1.Division of Bioengineering School of Chemical and Biomedical EngineeringNanyang Technological UniversitySingaporeRepublic of Singapore
  2. 2.School of Materials Science and EngineeringSouth China University of TechnologyGuangzhouChina
  3. 3.Key Laboratory of Specially Functional Materials and Advanced Manufacturing Technology, Ministry of EducationSouth China University of TechnologyGuangzhouChina

Personalised recommendations